Intravenous Cangrelor Vs Oral Ticagrelor in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention: A Randomised Controlled Trial

Salahaddin Ubaid,Thomas J Ford,Colin Berry,Benjamin Wrigley,Mark Thomas,Heather Murray, J Vickers, Armesilla,Jon Townend,Saib Khogali,Shahzad Munir,Joe Martins, R Jaumdally,Elisa J McAlindon,James M Cotton

Clinical medicine（2019）

引用 0|浏览60

暂无评分

摘要

Despite advances in ST-segment elevation myocardial infarction (STEMI) treatment, a sizeable minority of patients suffer poor outcomes even when treated with timely primary percutaneous intervention (PPCI). More potent P2Y12 inhibition improves clinical outcomes, however, oral agents have a slow

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要